Shenzhen BioX Medical Co., Ltd. is a professional manufacturer specializing in molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment. Established in 2017, the company is headquartered in Shenzhen, China, the global epicenter for biotechnology innovation and high-end medical device manufacturing.
Operating a modern facility exceeding 9,000 square meters with a workforce of over 200 experts, BioX Medical integrates R&D, production, and supply chains for molecular diagnostic technologies serving clinical labs and research institutions worldwide.
From North America to the Asia-Pacific, BioX Medical serves a diverse clientele with reliable, scalable diagnostic systems. We provide flexible OEM and ODM services for distributors and healthcare organizations seeking customized molecular testing solutions.
In the modern industrial and clinical landscape, Risk Assessment Tools have evolved from simple checklists to complex, AI-driven diagnostic ecosystems. As a leading China-based supplier and exporter, Shenzhen BioX Medical Co., Ltd. recognizes that "risk" in a laboratory context encompasses analytical accuracy, diagnostic speed, and data integrity. Our systems are designed to mitigate these risks by providing definitive molecular insights.
The global demand for risk assessment in healthcare has been catalyzed by the need for early pathogen detection and genetic predisposition mapping. Whether it's managing the risk of a feline infectious peritonitis (FIPV) outbreak in a veterinary clinic or assessing chromosome karyotype abnormalities in a prenatal lab, the reliability of the hardware is the first line of defense. BioX Medical leverages advanced Real-Time PCR (qPCR) and Next-Generation Sequencing (NGS) technologies to provide this vital data.
Our roadmap focuses on three core pillars:
Located in Shenzhen, BioX Medical benefits from the world's most robust electronics and biotech supply chain. This allows us to maintain unmatched manufacturing efficiency, rapid prototyping cycles, and cost-effective production without compromising on the stringent quality control standards required for medical-grade equipment.
Global exportation requires deep understanding of local regulatory frameworks (CE, FDA, ISO). Our team provides comprehensive localization support, including software translation, voltage adaptation, and regulatory documentation assistance, ensuring that our risk assessment tools are ready for immediate deployment in any jurisdiction.
Automated genetic testing for hereditary diseases and oncology, reducing the risk of misdiagnosis through high-resolution imaging.
Detecting viral loads in livestock and pets, preventing the economic and emotional risk of widespread disease outbreaks.
From transformer internal condition monitoring to geological diamond coring rig performance, we assess technical risk to prevent catastrophic failure.
BioX Medical combines Chinese manufacturing scale with rigorous R&D, offering a multidisciplinary portfolio that spans from molecular diagnostics to industrial monitoring, all backed by international quality certifications.
Yes, our advanced diagnostic platforms are designed with cloud-based data management and open API capabilities to ensure seamless integration with local Laboratory Information Systems.
We maintain strategic reserves of critical components and leverage Shenzhen's logistical hub status to ensure consistent delivery timelines, even during global supply chain fluctuations.
Absolutely. Our export team provides the necessary technical dossiers and performance data to assist our partners in obtaining local health and safety certifications.
BioX Medical
